Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantNYPRAX PHARMA PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
INTRAVENOUS
Medical Information
L01AC01
Manufacturer Information
NYPRAX PHARMA PTE. LTD.
Thymoorgan Pharmazie GmbH
Active Ingredients
Documents
Package Inserts
THIOTEPA RIEMSER POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION PI.pdf
Approved: June 20, 2024